Malignant Peripheral Nerve Sheath Tumor Clinical Trials

16 clinical trials for Malignant Peripheral Nerve Sheath Tumor across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors — RECRUITING · PHASE1
• SPEARHEAD-3 Pediatric Study — RECRUITING · PHASE1
• NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) — RECRUITING · PHASE1
• Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST — RECRUITING · PHASE1
• IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) — RECRUITING · PHASE2
• Neurofibromatosis Type 1 Tumor Early Detection Study — ACTIVE_NOT_RECRUITING
• Natural History Study of Patients With Neurofibromatosis Type I — ACTIVE_NOT_RECRUITING
• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery — COMPLETED · PHASE2
• Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients — COMPLETED · PHASE1
• Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma — NOT_YET_RECRUITING · NA
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma — COMPLETED · PHASE2
• HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors — COMPLETED · PHASE1
• Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) — TERMINATED · PHASE1
• Sorafenib and Dacarbazine in Soft Tissue Sarcoma — COMPLETED · PHASE2

Refine this search